Oral Isotretinoin Therapy: Use in a Patient with Multiple Cutaneous Squamous Cell Carcinomas and Keratoacanthomas

Archives of Dermatology

Volumn 120, Issue 9, 1984, Pages 1215-1217

  Levine, Norman ^a   Miller, Richard C ^a   Meyskens, Frank Louis ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

AGED; CASE REPORT; DRUG THERAPY; HISTOLOGY; HUMAN; KERATOACANTHOMA; ORAL DRUG ADMINISTRATION; SQUAMOUS CELL CARCINOMA; THERAPY; TUMOR REGRESSION;

ADMINISTRATION, ORAL; AGED; CARCINOMA, SQUAMOUS CELL; CASE REPORT; FEMALE; HUMAN; ISOTRETINOIN; KERATOACANTHOMA; LEG; SKIN DISEASES; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TRETINOIN;

EID: 0021152033     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1984.01650450097029     Document Type: Article

References (18)

1. Mayer H, Bollag W, Hanni R, et al: Retinoids: A new class of compounds with prophylactic and therapeutic activities in oncology and dermatology. Experientia 1978;34:1105–1119.
2. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 1980;605:33–91.
3. Koch HF: Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid. J Maxillofac Surg 1978;6:59–63.
4. Moriarity M, Dunn J, Darragh A, et al: Etretinate in treatment of actinic keratosis. Lancet 1982;1:364–365.
5. Peck GL, Olson TG, Butkus D, et al: Treatment of basal cell carcinomas with 13 cis retinoic acid. Proc Assoc Cancer Res 1979;20:56–58.
6. Levine N, Meyskens FL Jr: Topical vitamin A acid therapy for cutaneous metastatic melanoma. Lancet 1980;2:224–226.
7. Haydey RP, Reed ML, Dzubow LM, et al: Treatment of keratoacanthomas with oral 13 cis retinoic acid. N Engl J Med 1980;303:560–562.
8. Meyskens FL Jr, Gilmartin E, Alberts DS, et al: Activity of 13 cis retinoic acid against squamous cancers and preneoplastic lesions. Cancer Treat Rep 1982;66:1315–1319.
9. Sporn MB: Retinoids and carcinogenesis. Nutr Rev 1977;35:65–69.
10. Chytil F, Ong DE: Mediation of retinoic acid-induced growth and anti-tumor activity. Nature 1976;260:49–51.
11. Dennert G, Lotan R: Effects of retinoic acid on the immune system: Stimulation of T-killer cell induction. Eur J Immunol 1978;8:23–29.
12. Lotan R, Dennert G: Stimulatory effects of vitamin A analogs on induction of cell-mediated cytotoxicity in vivo. Cancer Res 1979;39:55–58.
13. Elias PM, Williams ML: Retinoids, cancer, and the skin. Arch Dermatol 1981;117:160–180.
14. Todaro GJ, De Larco G, Sporn MB: Retinoids block phenotypic cell transformation produced by sarcoma growth factor. Nature 1978;296:272–274.
15. Sporn M, Newton DL: Chemoprevention of cancer with retinoids. Fed Proc 1979;38:2428–2534.
16. Lasnitzki I: Reversal of methylcholanthrene induced changes in mouse prostates in-vivo by retinoic acid and its analogues. Br J Cancer 1978;34:239–248.
17. Chu EW, Malingren RA: An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic polycyclic hydrocarbons. Cancer Res 1965;25:884–885.
18. Davis RE: The effects of vitamin A on 7,12-dimethylbenz (a) anthracene-induced papillomas in rhino mouse skin. Cancer Res 1967;27:237–241.